SIWA Therapeutics, Inc

SIWA's mAb kills senescent cells; we are commencing pre-clinical work leading to filing of an IND for a cancer in about 16 months.

  • Stage Prototype Ready
  • Industry Biotechnology
  • Location Chicago, IL, US
  • Currency USD
  • Founded August 2006
  • Employees 4
  • Incorporation Type C-corp
  • Website siwatherapeutics.com

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free